𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosis

✍ Scribed by T. Trenque; N. Simon; I. Villena; C. Chemla; C. Quereux; B. Leroux; R. Jaussaud; G. Rémy; D. Dupouy; H. Millart; J.-M. Pinon; S. Urien

Book ID
108640110
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
192 KB
Volume
57
Category
Article
ISSN
0306-5251

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Congenital toxoplasmosis: value of prena
Congenital toxoplasmosis: value of prenatal treatment with pyrimethamine-sulfadoxine combination
✍ I. Villena; C. Quereux; J. M. Pinon 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

fluorochrome-labelled nucleotides (Isola et al., 1994), such that all chromosomes can be included in the analysis. This novel approach combines screening for aneuploidy by CGH with precise mapping and sampling of the term placenta, separation of the placental cell lineages, and quantification of mo

A randomized safety and tolerability tri
A randomized safety and tolerability trial of artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone for the treatment of uncomplicated malaria in Gambian children
✍ J.F. Doherty; A.D. Sadiq; L. Bayo; A. Alloueche; P. Olliaro; P. Milligan; L. von 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 474 KB

Artemisinin derivatives, such as artesunate, have a short half-life and very rapid anti-malarial activity. Theoretically, using such agents in conjunction with well-established anti-malarial drugs such as sulfadoxine-pyrimethamine may reduce the rate of drug resistance. Such a combination has not pr